Pancreatic Cancer Research

ResearcherUniversity of MiamiNo recent work listed

Patricia Dauer

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-8374-5512; OpenAlex author ID A5059089028. Sources: OpenAlex.

Their work

Papers
9
Trials
0
Grants
0
Labs led
0
Collaborators
13
Papers, trials and grants by year

2016: 1 paper · 2017: 3 papers · 2018: 3 papers · 2019: 2 papers

Papers 9

  1. ER stress sensor, glucose regulatory protein 78 (GRP78) regulates redox status in pancreatic cancer thereby maintaining "stemness". Co-author DOI 10.1038/s41419-019-1408-5↗
  2. O-GlcNAc modification of Sox2 regulates self-renewal in pancreatic cancer by promoting its stability. Co-author DOI 10.7150/thno.32615↗
  3. GRP78-mediated antioxidant response and ABC transporter activity confers chemoresistance to pancreatic cancer cells. Co-author DOI 10.1002/1878-0261.12322↗
  4. Metastasis and chemoresistance in CD133 expressing pancreatic cancer cells are dependent on their lipid raft integrity. Co-author DOI 10.1016/j.canlet.2018.09.028↗
  5. Inactivation of Cancer-Associated-Fibroblasts Disrupts Oncogenic Signaling in Pancreatic Cancer Cells and Promotes Its Regression. Co-author DOI 10.1158/0008-5472.can-17-2320↗
  6. Microenvironment in determining chemo-resistance in pancreatic cancer: Neighborhood matters. Co-author DOI 10.1016/j.pan.2016.12.010↗
  7. Inhibition of Sp1 prevents ER homeostasis and causes cell death by lysosomal membrane permeabilization in pancreatic cancer. Co-author DOI 10.1038/s41598-017-01696-2↗
  8. Inhibition of hypoxic response decreases stemness and reduces tumorigenic signaling due to impaired assembly of HIF1 transcription complex in pancreatic cancer. Co-author DOI 10.1038/s41598-017-08447-3↗
  9. Inhibition of NF-kappa B pathway leads to deregulation of epithelial-mesenchymal transition and neural invasion in pancreatic cancer. Co-author DOI 10.1038/labinvest.2016.109↗

Closest collaborators

The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Sulagna Banerjee · 9 shared papers, 2016–2019 · strength 0.72
  2. Ashok Kumar Saluja · 9 shared papers, 2016–2019 · strength 0.72
  3. Vikas Dudeja · 8 shared papers, 2016–2019 · strength 0.63
  4. Vineet Kumar Gupta · 7 shared papers, 2017–2019 · strength 0.56
  5. Nikita Sharma · 7 shared papers, 2017–2019 · strength 0.56
  6. Alice Nomura · 6 shared papers, 2016–2018 · strength 0.47
  7. Bhuwan Giri · 4 shared papers, 2016–2019 · strength 0.29
  8. Santanu Banerjee · 3 shared papers, 2018–2019 · strength 0.26
  9. Kousik Kesh · 3 shared papers, 2018–2019 · strength 0.24
  10. Selwyn Maurice Vickers · 2 shared papers, 2018–2019 · strength 0.16
  11. Olivia McGinn · 2 shared papers, 2017 · strength 0.14
  12. Xianda Zhao · 1 shared paper, 2018 · strength 0.08
  13. Kaustav Majumder · 1 shared paper, 2016 · strength 0.06

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.